Premium
Belite Bio Inc (BLTE)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Lin BioScience, Inc. | Institution | 17 095 263 | 43,46% | US$ 2,47B | 2025-03-14 |
| Darwin Global Management Limited | Institution | 3 057 412 | 7,77% | US$ 441,67M | 2026-03-31 |
| Darwin Global Master Fund, Ltd. | Institution | 2 527 589 | 6,42% | US$ 365,14M | 2025-12-03 |
| Paradigm Biocapital Advisors LP | Institution | 1 114 784 | 2,83% | US$ 161,04M | 2026-03-31 |
| UBS Asset Management AG | Institution | 768 359 | 1,95% | US$ 111,00M | 2026-03-31 |
| RTW Investments, LP | Institution | 715 332 | 1,82% | US$ 103,34M | 2026-03-31 |
| Millennium Management LLC | Institution | 570 088 | 1,45% | US$ 82,35M | 2026-03-31 |
| Holocene Advisors, LP | Institution | 494 495 | 1,26% | US$ 71,43M | 2026-03-31 |
| Eventide Asset Management, LLC | Institution | 357 650 | 0,91% | US$ 51,67M | 2026-03-31 |
| Dr. Yu-Hsin Lin | Initiés | 353 883 | 0,90% | US$ 51,12M | 2026-04-21 |
| Deerfield Management Company, L.P. | Institution | 304 013 | 0,77% | US$ 43,92M | 2026-03-31 |
| Mr. Hao-Yuan Chuang | Initiés | 299 064 | 0,76% | US$ 43,20M | 2026-04-21 |
| T. Rowe Price Group, Inc. | Institution | 281 805 | 0,72% | US$ 40,71M | 2026-03-31 |
| Morgan Stanley | Institution | 158 043 | 0,40% | US$ 22,83M | 2026-03-31 |
| Perceptive Advisors LLC | Institution | 151 979 | 0,39% | US$ 21,95M | 2026-03-31 |
| Patient Square Capital, LP | Institution | 116 684 | 0,30% | US$ 16,86M | 2026-03-31 |
| Duquesne Family Office LLC | Institution | 106 100 | 0,27% | US$ 15,33M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 105 509 | 0,27% | US$ 15,24M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 88 045 | 0,22% | US$ 12,72M | 2026-03-31 |
| Fubon Asset Management Co., Ltd. | Institution | 79 895 | 0,20% | US$ 11,54M | 2026-03-31 |
| Uni-President Assets Management Corp. | Institution | 65 828 | 0,17% | US$ 9,51M | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 65 000 | 0,17% | US$ 9,39M | 2026-03-31 |
| Fred Alger Management, LLC | Institution | 62 574 | 0,16% | US$ 9,04M | 2026-03-31 |
| PFM Health Sciences, LP | Institution | 59 432 | 0,15% | US$ 8,59M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 52 000 | 0,13% | US$ 7,51M | 2026-03-31 |
| Morgan Stanley Investment Management Inc. | Institution | 42 036 | 0,11% | US$ 6,07M | 2026-03-31 |
| Longaeva Partners L.P. | Institution | 33 492 | 0,09% | US$ 4,84M | 2026-03-31 |
| TD Asset Management, Inc. | Institution | 33 410 | 0,08% | US$ 4,83M | 2026-03-31 |
| Ms. Wan-Shan Chen | Initiés | 32 559 | 0,08% | US$ 4,70M | 2026-04-09 |
| BNP Paribas Financial Markets SNC | Institution | 32 525 | 0,08% | US$ 4,70M | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 26 880 | 0,07% | US$ 3,88M | 2026-03-31 |
| Artia Global Partners LP | Institution | 24 989 | 0,06% | US$ 3,61M | 2026-03-31 |
| Quadrature Capital Limited | Institution | 23 708 | 0,06% | US$ 3,42M | 2026-03-31 |
| Aquatic Capital Management LLC | Institution | 20 294 | 0,05% | US$ 2,93M | 2026-03-31 |
| Manulife Asset Management | Institution | 19 600 | 0,05% | US$ 2,83M | 2026-03-31 |
| Squarepoint OPS LLC | Institution | 16 981 | 0,04% | US$ 2,45M | 2026-03-31 |
| Dr. Nathan Mata | Initiés | 16 666 | 0,04% | US$ 2,41M | 2026-05-07 |
| Medical Strategy GmbH | Institution | 16 600 | 0,04% | US$ 2,40M | 2025-12-31 |
| State Street Global Advisors, Inc. | Institution | 16 048 | 0,04% | US$ 2,32M | 2026-03-31 |
| BMO Asset Management Corp. | Institution | 15 981 | 0,04% | US$ 2,31M | 2026-03-31 |
| Trexquant Investment LP | Institution | 15 072 | 0,04% | US$ 2,18M | 2026-03-31 |
| XTX Markets Limited | Institution | 15 058 | 0,04% | US$ 2,18M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
